InvestorsHub Logo
Followers 73
Posts 10908
Boards Moderated 1
Alias Born 10/02/2009

Re: None

Wednesday, 06/25/2014 12:58:55 AM

Wednesday, June 25, 2014 12:58:55 AM

Post# of 11554
Biotech Implications for Quantum Dots..Emerging Nanotechnology.

Quantum Materials Exhibitor & Invited Speaker Molecular Medicine Tri-Conference, Moscone Center, San Francisco, February 11-13 2013. Mr Squires Topic, Tetrapod Quantum Dot's Applications in Emerging Nano Molecular Medicine & Diagnostics, Ranging from Imaging Assays, Multiplex Drug Delivery & Cellular Targeting Platforms.

Quantum Dots are the future of molecular medicine and biotech, in assays, diagnostics, theranostics, drug delivery and point-of-care devices.

"Green" quantum dot synthesis approach using continuous flow chemistry mass production can dramatically lower the cost of energy transfer conjugates, while delivering better features, and more accurate results and outcomes. These quantum dots are Tetrapod shape, uniform, low cost and mass producible.

Biomedical Research assays using tetrapod quantum dots instead of chromophores and florophores have advantages of brightness, stability and reacton time for more accurate treatments & diagnosis. Quantum dots coupled with biomarkers, allow diagnosis of disease which can become point of care care devies in doctor's offices with instant readouts. Bio-compatable Tetrapod QD used in a multiplexing drug delivery platform is also being explored for diagnosis, treatment and eradication of cancer cells. For many biotech applications the ultimate "enabling technology' will be easily synthesized and scaled high quantum dot yield and uniform quantum dots.

Quantum Materials Corporation is developing specialized quantum dots for a private biotech company, Nanoaxis LLC to functionalize with their proprietary biomedical nanomaterials for a multiplexing drug delivery platform for drug/gene therapy and diagnostic medical devices technologies. Quantum Materials' CEO Stephen Squires will report on this joint alliance and our progress developing new quantum dots at the CHI Emerging Diagnostics partnership Forum in San Francisco on February 11th.

For More Information "Review of Quantum Dot Technologies for Cancer Detection and Treatment" http://www.azonano.com/article.aspx?ArticleID=1726

Quantum Materials QTMM OTC-QB is Emerging Mass Producer of Tetrapod Quantum Dots Not a p/d more L/T Investment

http://ih.advfn.com/p.php?pid=nmona&article=62623214

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.